Off-patent small molecule and biologic drug supply with bioequivalent and biosimilar alternatives — the therapeutically equivalent medications providing 80-90% cost reduction versus originator brands representing the volume-dominant segment in global pharmaceutical consumption — creates the most healthcare-cost-saving market segment, with the Generic Medicine Market reflecting...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
